Research Library

Fellow in Energy and Global Oil, Mark Finley, comments on the 2024 edition of the Energy Institute’s “Statistical Review of World Energy” and points out some new wrinkles, a lot of continuity, and the mixed message left by the world of energy in 2023.

Medical providers are increasingly asking patients about their access to food, housing, and transportation. In this commentary, fellow Elena M. Marks explores how this type of screening for non-medical needs offers significant benefits for both patients and providers — even when providers cannot address those needs.

Two specific issues — the Russia-Ukraine war and the Israel-Hamas war — have propelled foreign policy to the forefront of this year’s election. Both conflicts are ongoing and have severely tested Biden and his foreign policy team, and ahead of November, Biden has little room for error.

In 2026, the USMCA will undergo an open-ended review that could result in anything from minor changes to significant renegotiations. Nonresident fellow Simon Lester discusses this unprecedented process and argues that the U.S. and Mexico must follow Canada’s lead in starting preparations.

No longer confined to the lab, genetically altered products are now being marketed to the public. This means the need for genetic biocontainment has shifted from the laboratory to the general environment.

Recent federal research security initiatives have put the U.S. at risk of losing its lead in science and technology, write senior fellow Neal F. Lane, Steven Pei, and Jeremy Wu. They lay out a path toward clear, fair policy that safeguards America’s security and competitiveness while fostering a welcoming research environment for foreign talent.

While the U.S. has tried to appear assertive in taking action against China’s trade practices, this strategy has yielded limited results. In a new commentary, fellow Simon Lester summarizes current U.S. policies addressing China’s trade conduct and advocates for the U.S.’ revitalized engagement with the World Trade Organization’s dispute settlement system.

The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.

The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.

Will OPEC+ begin to reverse large production cuts at its June 1 meeting? In large part, it will depend on whose oil market outlook is closest to the mark, writes Mark Finley, fellow in energy and global oil. He examines several forecasts and outlines the issues in a new commentary.